Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.

The unparalleled success of combination antiretroviral therapy (cART) is based on the combination of three drugs from two classes. There is insufficient evidence whether simplification to ritonavir boosted protease inhibitor (PI/r) monotherapy in virologically suppressed HIV-infected patients is eff...

Full description

Bibliographic Details
Main Authors:	Sandra Mathis, Bettina Khanlari, Federico Pulido, Mauro Schechter, Eugenia Negredo, Mark Nelson, Pietro Vernazza, Pedro Cahn, Jean-Luc Meynard, Jose Arribas, Heiner C Bucher
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3139616?pdf=render

Similar Items

Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy.
by: Ignacio Pérez-Valero, et al.
Published: (2013-01-01)

Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile.
by: José R Santos, et al.
Published: (2012-01-01)

The Place of protease inhibitors in antiretroviral treatment
by: S.B. Tenore, et al.

Antiretroviral activity of protease inhibitors against Toxoplasma gondii Terapia antiretroviral de inibidores da protease contra Toxoplasma gondii
by: Lianet Monzote, et al.
Published: (2013-02-01)

The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection
by: Nicholas I Paton, et al.
Published: (2016-03-01)

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
by: Katherine A Sutherland, et al.
Published: (2015-01-01)

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.
by: Luis F López-Cortés, et al.
Published: (2016-01-01)

The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK
by: Edwards SC, et al.
Published: (2016-11-01)

HIV-1 protease as a target for antiretroviral therapy
by: Windsor, Ian William.
Published: (2019)

Antiretroviral activity of protease inhibitors against Toxoplasma gondii
by: Lianet Monzote, et al.
Published: (2013-02-01)

Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
by: Katherine A Sutherland, et al.
Published: (2016-01-01)

Leg oedema due to low-dose risperidone during maintenance monotherapy of schizophrenia
by: Serhat Tunç, et al.
Published: (2018-01-01)

The intracellular pharmacology of the antiretroviral protease inhibitors in a clinical setting
by: Ford, Jennifer
Published: (2004)

Comparison of Preterm Delivery Rates between HIV-infected Pregnant Women Receiving Highly Active Antiretroviral Therapy (HAART) Containing Protease Inhibitors (PIs) and HIV-infected Pregnant Women Receiving Zidovudine Monotherapy
by: Bongkot Chakornbandit, et al.
Published: (2015-09-01)

ANTIRETROVIRAL DRUGS EFAVIRENZ AND TENOFOVIR AND THEIR EFFECTS ON ARTERIAL REMODELING AND PROTEASE ACTIVITY
by: Roberts, Ladeidra Monet
Published: (2015)

Oxcarbazepine Monotherapy
by: J Gordon Millichap
Published: (2006-10-01)

Oxcarbazepine in Monotherapy
by: Mogens Dam
Published: (1990-01-01)

Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy
by: Yang Hailiu, et al.
Published: (2012-09-01)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
by: Ruxandra-Cristina Marin, et al.
Published: (2021-03-01)

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
by: Hellen Musana, et al.
Published: (2021-04-01)

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.
by: Rami Kantor, et al.
Published: (2005-04-01)

Effect of the African Traditional Medicine, Sutherlandia frutescens, on the Bioavailability of the Antiretroviral Protease Inhibitor, Atazanavir
by: Adrienne C. Müller, et al.
Published: (2013-01-01)

Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon
by: Bley Daniel, et al.
Published: (2009-07-01)

Topiramate Monotherapy in Epilepsy
by: J Gordon Millichap
Published: (2009-09-01)

In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice.
by: Ambalika Sarkar, et al.
Published: (2020-01-01)

Outcomes of protease inhibitor-based antiretroviral therapy amongst children and associated-factors in Yaoundé, Cameroon.
by: Anne Esther Njom Nlend, et al.
Published: (2019-01-01)

Response to a Protease-Inhibitor (Ritonavir)-Containing Combination Antiretroviral Regimen in HIV-Infected Children
by: Upton D Allen, et al.
Published: (2003-01-01)

Antiretroviral drug susceptibility of a hinge region variant of HIV-1 subtype C protease
by: Zondagh, Jake
Published: (2018)

Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, Cameroon
by: Bley Daniel, et al.
Published: (2009-07-01)

CHOICE OF ALTERNATIVE MONOTHERAPY IN EPILEPSY
by: I. Ju. Kovaleva
Published: (2016-05-01)

The principles for prescribing estrogen monotherapy
by: T. V. Ovsyannikova, et al.
Published: (2015-12-01)

Vigabatrin Monotherapy for Infantile Spasms
by: J Gordon Millichap
Published: (1995-03-01)

Side Effects of Anticonvulsant Monotherapy
by: J Gordon Millichap
Published: (1989-01-01)

Hormone Profiles with Valproate Monotherapy
by: J Gordon Millichap
Published: (2001-09-01)

Acetazolamide Monotherapy for Myoclonic Epilepsy
by: J Gordon Millichap
Published: (1990-11-01)

Cognitive Function and Valproate Monotherapy
by: J Gordon Millichap
Published: (1996-09-01)

Quetiapine monotherapy for bipolar depression
by: Michael E Thase
Published: (2008-03-01)

Monotherapy with liraglutide – Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Gabapentin Monotherapy for Refractory Seizures
by: J Gordon Millichap
Published: (1997-10-01)

Gabapentin Monotherapy for Partial Seizures
by: J Gordon Millichap
Published: (1998-12-01)

Cannot write session to /tmp/vufind_sessions/sess_ulkpm0ftg69i48eq5nosmrcm5o